Info Button Test development.

gistfile1.txt

Request:


url : http://localhost:8080/api/_search/trials/infobutton?page=0&size=20&sort=briefTitle,desc&q=%5Bobject%20Object%5D

Headers :
[{"key":"content-type","value":"application/json","description":""},
{"key":"Accept","value":"application/atom+xml","description":""}]

body

{
	"infoButtonKnowledgeRequests" : [
			{
				"key" :"age.v.v.v",
				"value" :"8"
			},
			{
				"key": "mainSearchCriteria.v.c.test",
				"value" : "250"
			},
			{
				"key": "taskContext.c.c",
				"value" : "PROBLISTREV"
			},
			{
				"key": "representedOrganization.id.root",
				"value" : "1.3.6.1.4.1.4275"
			},
			{
				"key": "mainSearchCriteria.v.dn",
				"value" : "Diabetes"
			},
			{
				"key": "mainSearchCriteria.v.cs",
				"value" : "2.16.840.1.113883.6.103"
			}
		]	
}


Response:


<String>&lt;?xml version="1.0" encoding="UTF-8"?>&#xd;
&lt;feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">&#xd;
  &lt;title>Termlex&lt;/title>&#xd;
  &lt;updated>2018-09-28T22:14:04Z&lt;/updated>&#xd;
  &lt;dc:date>2018-09-28T22:14:04Z&lt;/dc:date>&#xd;
  &lt;entry>&#xd;
    &lt;title>A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS &amp;amp; AML Patients&lt;/title>&#xd;
    &lt;category term="mainSearchCriteria.v.cs" />&#xd;
    &lt;author>&#xd;
      &lt;name />&#xd;
    &lt;/author>&#xd;
  &lt;/entry>&#xd;
  &lt;entry>&#xd;
    &lt;title>Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation&lt;/title>&#xd;
    &lt;category term="mainSearchCriteria.v.cs" />&#xd;
    &lt;author>&#xd;
      &lt;name />&#xd;
    &lt;/author>&#xd;
  &lt;/entry>&#xd;
  &lt;entry>&#xd;
    &lt;title>Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy&lt;/title>&#xd;
    &lt;category term="mainSearchCriteria.v.cs" />&#xd;
    &lt;author>&#xd;
      &lt;name />&#xd;
    &lt;/author>&#xd;
  &lt;/entry>&#xd;
  &lt;entry>&#xd;
    &lt;title>Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia&lt;/title>&#xd;
    &lt;category term="mainSearchCriteria.v.cs" />&#xd;
    &lt;author>&#xd;
      &lt;name />&#xd;
    &lt;/author>&#xd;
  &lt;/entry>&#xd;
  &lt;entry>&#xd;
    &lt;title>Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma&lt;/title>&#xd;
    &lt;category term="mainSearchCriteria.v.cs" />&#xd;
    &lt;author>&#xd;
      &lt;name />&#xd;
    &lt;/author>&#xd;
  &lt;/entry>&#xd;
  &lt;entry>&#xd;
    &lt;title>Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)&lt;/title>&#xd;
    &lt;category term="mainSearchCriteria.v.cs" />&#xd;
    &lt;author>&#xd;
      &lt;name />&#xd;
    &lt;/author>&#xd;
  &lt;/entry>&#xd;
  &lt;entry>&#xd;
    &lt;title>Masitinib in combination with dexamethasone and gemcitabine for relapse / refractory T cell lymphoma&lt;/title>&#xd;
    &lt;category term="mainSearchCriteria.v.cs" />&#xd;
    &lt;author>&#xd;
      &lt;name />&#xd;
    &lt;/author>&#xd;
  &lt;/entry>&#xd;
&lt;/feed>&#xd;</String>